HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
Abstract Background Holliday junction recognition protein (HJURP) has been implicated in many cancers including hepatocellular carcinoma (HCC). However, the underlying mechanism by which HJURP promotes HCC cell proliferation remains unclear. Methods RT-qPCR and immunohistochemistry were used to dete...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0866-4 |
_version_ | 1818894116503683072 |
---|---|
author | Tianchi Chen Hechen Huang Yuan Zhou Lei Geng Tian Shen Shengyong Yin Lin Zhou Shusen Zheng |
author_facet | Tianchi Chen Hechen Huang Yuan Zhou Lei Geng Tian Shen Shengyong Yin Lin Zhou Shusen Zheng |
author_sort | Tianchi Chen |
collection | DOAJ |
description | Abstract Background Holliday junction recognition protein (HJURP) has been implicated in many cancers including hepatocellular carcinoma (HCC). However, the underlying mechanism by which HJURP promotes HCC cell proliferation remains unclear. Methods RT-qPCR and immunohistochemistry were used to detect HJURP expression in HCC and adjacent tumor tissues and HCC cell lines. The localization of p21 were determined by immunofluorescence and western blot. Co-immunoprecipitation and western blot were used to validate the p21 stability and signaling pathways affected by HJURP. The effects of HJURP on HCC cell proliferation were assessed both in vivo and in vitro. The ERK1/2 pathway inhibitor U0126 and AKT pathway agonist SC-79 were used to treat HCC cell lines for further mechanistic investigations. Results HJURP expression was higher in HCC tissues than in para-tumor tissues. Moreover, ectopic HJURP expression facilitated the proliferation of HCC cells, whereas the depletion of HJURP resulted in decreased cell growth in vitro and in vivo. Furthermore, the effects of HJURP silencing were reversed by p21 knockdown. Likewise, p21 overexpression inhibited cell growth ability mediated by HJURP elevation. Mechanistically, HJURP destabilized p21 via the MAPK/ERK1/2 and AKT/GSK3β pathways, which regulated the nucleus-cytoplasm translocation and ubiquitin-mediated degradation of p21. Clinically, high HJURP expression was correlated with unfavorable prognoses in HCC individuals. Conclusions Our data revealed that HJURP is an oncogene that drives cell cycle progression upstream of p21 in HCC. These findings may provide a potential therapeutic and prognostic target for HCC. |
first_indexed | 2024-12-19T18:23:23Z |
format | Article |
id | doaj.art-c18b5dcefb1d4931bc62bc8b1c807db7 |
institution | Directory Open Access Journal |
issn | 1756-9966 |
language | English |
last_indexed | 2024-12-19T18:23:23Z |
publishDate | 2018-08-01 |
publisher | BMC |
record_format | Article |
series | Journal of Experimental & Clinical Cancer Research |
spelling | doaj.art-c18b5dcefb1d4931bc62bc8b1c807db72022-12-21T20:10:55ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662018-08-0137111410.1186/s13046-018-0866-4HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathwaysTianchi Chen0Hechen Huang1Yuan Zhou2Lei Geng3Tian Shen4Shengyong Yin5Lin Zhou6Shusen Zheng7Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public HealthKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public HealthDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityAbstract Background Holliday junction recognition protein (HJURP) has been implicated in many cancers including hepatocellular carcinoma (HCC). However, the underlying mechanism by which HJURP promotes HCC cell proliferation remains unclear. Methods RT-qPCR and immunohistochemistry were used to detect HJURP expression in HCC and adjacent tumor tissues and HCC cell lines. The localization of p21 were determined by immunofluorescence and western blot. Co-immunoprecipitation and western blot were used to validate the p21 stability and signaling pathways affected by HJURP. The effects of HJURP on HCC cell proliferation were assessed both in vivo and in vitro. The ERK1/2 pathway inhibitor U0126 and AKT pathway agonist SC-79 were used to treat HCC cell lines for further mechanistic investigations. Results HJURP expression was higher in HCC tissues than in para-tumor tissues. Moreover, ectopic HJURP expression facilitated the proliferation of HCC cells, whereas the depletion of HJURP resulted in decreased cell growth in vitro and in vivo. Furthermore, the effects of HJURP silencing were reversed by p21 knockdown. Likewise, p21 overexpression inhibited cell growth ability mediated by HJURP elevation. Mechanistically, HJURP destabilized p21 via the MAPK/ERK1/2 and AKT/GSK3β pathways, which regulated the nucleus-cytoplasm translocation and ubiquitin-mediated degradation of p21. Clinically, high HJURP expression was correlated with unfavorable prognoses in HCC individuals. Conclusions Our data revealed that HJURP is an oncogene that drives cell cycle progression upstream of p21 in HCC. These findings may provide a potential therapeutic and prognostic target for HCC.http://link.springer.com/article/10.1186/s13046-018-0866-4HJURPProliferationp21Hepatocellular carcinoma |
spellingShingle | Tianchi Chen Hechen Huang Yuan Zhou Lei Geng Tian Shen Shengyong Yin Lin Zhou Shusen Zheng HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways Journal of Experimental & Clinical Cancer Research HJURP Proliferation p21 Hepatocellular carcinoma |
title | HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways |
title_full | HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways |
title_fullStr | HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways |
title_full_unstemmed | HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways |
title_short | HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways |
title_sort | hjurp promotes hepatocellular carcinoma proliferation by destabilizing p21 via the mapk erk1 2 and akt gsk3β signaling pathways |
topic | HJURP Proliferation p21 Hepatocellular carcinoma |
url | http://link.springer.com/article/10.1186/s13046-018-0866-4 |
work_keys_str_mv | AT tianchichen hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT hechenhuang hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT yuanzhou hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT leigeng hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT tianshen hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT shengyongyin hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT linzhou hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways AT shusenzheng hjurppromoteshepatocellularcarcinomaproliferationbydestabilizingp21viathemapkerk12andaktgsk3bsignalingpathways |